Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.93 USD | -0.51% | +3.69% | +86.26% |
03/05 | Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating | MT |
02/05 | Geron Shares Decline After Q1 Loss Widens | MT |
Business Summary
Number of employees: 141
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products for Oncology
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -60.23% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -60.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Scarlett
CEO | Chief Executive Officer | 73 | 29/11/29 |
Director of Finance/CFO | 57 | 25/23/25 | |
Faye Feller
CTO | Chief Tech/Sci/R&D Officer | 42 | 01/19/01 |
Andrew Grethlein
COO | Chief Operating Officer | 59 | 17/12/17 |
Aron Feingold
IRC | Investor Relations Contact | - | 01/22/01 |
Shannon Odam
HRO | Human Resources Officer | - | 20/19/20 |
Edward E. Koval
PRN | Corporate Officer/Principal | 62 | 01/21/01 |
Anil Kapur
PRN | Corporate Officer/Principal | 54 | 03/19/03 |
Scott Samuels
LAW | General Counsel | 54 | - |
Corporate Officer/Principal | 59 | 01/98/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
V. Lawlis
BRD | Director/Board Member | 72 | 15/12/15 |
John Scarlett
CEO | Chief Executive Officer | 73 | 29/11/29 |
Susan Molineaux
BRD | Director/Board Member | 70 | 28/12/28 |
Gaurav Aggarwal
BRD | Director/Board Member | 51 | 28/11 |
John McDonald
BRD | Director/Board Member | 63 | 07/22/07 |
Robert Spiegel
BRD | Director/Board Member | 73 | 19/10/19 |
Director/Board Member | 59 | 26/19/26 | |
Dawn Bir
BRD | Director/Board Member | 53 | 26/19/26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 586,912,213 | 586,395,969 ( 99.91 %) | 0 | 99.91 % |
Company contact information
Geron Corp.
919 East Hillsdale Boulevard Suite 250
94404, Foster City
+650 473 7700
http://www.geron.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+86.26% | 2.31B | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- GERN Stock
- Company Geron Corporation